Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Here you can browse the complete list of publications for studies listed on CDAS.

Studies
Publication Year

Results: 975 (Showing 81 to 100) — Export these results

Title PubMed Id Authors Journal Abbreviation Year Studies
The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort. 29161239 Kawakita D, Lee YA, Gren LH, Buys SS, La Vecchia C, Hashibe M Br. J. Cancer 2018 PLCO
A dietary pattern based on estrogen metabolism is associated with breast cancer risk in a prospective cohort of postmenopausal women. 29574860 Guinter MA, McLain AC, Merchant AT, Sandler DP, Steck SE Int. J. Cancer 2018 PLCO
Association of Nonadherence to Cancer Screening Examinations With Mortality From Unrelated Causes: A Secondary Analysis of the PLCO Cancer Screening Trial. 30592477 Pierre-Victor D, Pinsky PF JAMA Intern Med 2018 PLCO
Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men. 29788475 Petrick JL, Hyland PL, Caron P, Falk RT, Pfeiffer RM, Dawsey SM, Abnet CC, Taylor PR, Weinstein SJ, Albanes D, Freedman ND, Gapstur SM, Bradwin G, Guillemette C, Campbell PT, Cook MB J. Natl. Cancer Inst. 2018 PLCO
Association of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence. 29800214 Click B, Pinsky PF, Hickey T, Doroudi M, Schoen RE JAMA 2018 PLCO
Concentrated sugars and incidence of prostate cancer in a prospective cohort. 30047347 Miles FL, Neuhouser ML, Zhang ZF Br. J. Nutr. 2018 PLCO
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. 29321194 Seibert TM, Fan CC, Wang Y, Zuber V, Karunamuni R, Parsons JK, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Garcia SB, Muir K, Grönberg H, Wiklund F, Aly M, Schleutker J, Sipeky C, Tammela TL, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, … BMJ 2018 PLCO
Association of Coffee and Tea Intake with the Oral Microbiome: Results from a Large Cross-Sectional Study. 29703763 Peters BA, McCullough ML, Purdue MP, Freedman ND, Um CY, Gapstur SM, Hayes RB, Ahn J Cancer Epidemiol. Biomarkers Prev. 2018 PLCO
Visual discrimination of screen-detected persistent from transient subsolid nodules: An observer study. 29438443 Chung K, Ciompi F, Scholten ET, Goo JM, Prokop M, Jacobs C, van Ginneken B, Schaefer-Prokop CM PLoS ONE 2018 NLST
AA9int: SNP Interaction Pattern Search Using Non-Hierarchical Additive Model Set. 29878078 Lin HY, Huang PY, Chen DT, Tung HY, Sellers TA, Pow-Sang J, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Hamdy F, Neal DE, Pashayan N, Kha… Bioinformatics 2018 PLCO
Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia. 30305637 McMaster ML, Berndt SI, Zhang J, Slager SL, Li SA, Vajdic CM, Smedby KE, Yan H, Birmann BM, Brown EE, Smith A, Kleinstern G, Fansler MM, Mayr C, Zhu B, Chung CC, Park JH, Burdette L, Hicks BD, Hutchinson A, Teras LR, Adami HO, Bracci PM, McKay J, Mo… Nat Commun 2018 PLCO
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. 29892050 Dadaev T, Saunders EJ, Newcombe PJ, Anokian E, Leongamornlert DA, Brook MN, Cieza-Borrella C, Mijuskovic M, Wakerell S, Olama AAA, Schumacher FR, Berndt SI, Benlloch S, Ahmed M, Goh C, Sheng X, Zhang Z, Muir K, Govindasami K, Lophatananon A, Stevens… Nat Commun 2018 PLCO
Germline variation at 8q24 and prostate cancer risk in men of European ancestry. 30397198 Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, Schumacher FR, Ingles SA, Govindasami K, Benlloch S, Berndt SI, Albanes D, Koutros S, Muir K, Stevens VL, Gapstur SM, Tangen CM, Batra J, Clements J, Gronberg H, Pashayan N, Sc… Nat Commun 2018 PLCO
Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium. 30121626 Cook MB, Barnett MJ, Bock CH, Cross AJ, Goodman PJ, Goodman GE, Haiman CA, Khaw KT, McCullough ML, Newton CC, Boutron-Ruault MC, Lund E, Rutegård M, Thornquist MD, Spriggs M, Giffen C, Freedman ND, Kemp T, Kroenke CH, Le Marchand L, Park JY, Simon M… Gut 2018 PLCO
Influence of Accelerometer Calibration Approach on Moderate-Vigorous Physical Activity Estimates for Adults. 29933344 Matthews CE, Keadle SK, Berrigan D, Staudenmayer J, F Saint-Maurice P, Troiano RP, Freedson PS Med Sci Sports Exerc 2018 IDATA
Lung cancer risk to personalise annual and biennial follow-up computed tomography screening. 29602813 Schreuder A, Schaefer-Prokop CM, Scholten ET, Jacobs C, Prokop M, van Ginneken B Thorax 2018 NLST
Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial. 30502933 Miller EA, Pinsky PF, Schoen RE, Prorok PC, Church TR Lancet Gastroenterol Hepatol 2018 PLCO
Aspirin Use and Mortality in Two Contemporary US Cohorts. 28863047 Huang WY, Daugherty SE, Shiels MS, Purdue MP, Freedman ND, Abnet CC, Hollenbeck AR, Hayes RB, Silverman DT, Berndt SI Epidemiology 2018 PLCO
A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium. 29114882 Barrdahl M, Canzian F, Gaudet MM, Gapstur SM, Trichopoulou A, Tsilidis K, van Gils CH, Borgquist S, Weiderpass E, Khaw KT, Giles GG, Milne RL, Le Marchand L, Haiman C, Lindström S, Kraft P, Hunter DJ, Ziegler R, Chanock SJ, Yang XR, Buring JE, Lee I… Int. J. Cancer 2018 PLCO
Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer. 29978465 Xu Y, Liu H, Liu S, Wang Y, Xie J, Stinchcombe TE, Su L, Zhang R, Christiani DC, Wei L, Wei Q Int. J. Cancer 2018 PLCO